Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluating Silymarin for Chronic Hepatitis C
This study has been completed.
Study NCT00030030   Information provided by National Center for Complementary and Alternative Medicine (NCCAM)
First Received: January 30, 2002   Last Updated: August 17, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hepatitis C, Chronic
Additional conditions recognized in this trial
Hepatitis
Hepatitis C
Hepatitis, Chronic
More general conditions related to this trial
Digestive System Diseases
Flaviviridae Infections
Hepatitis, Viral, Human
Liver Diseases
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
Silymarin (milk thistle)
Additional drug interventions recognized in this trial
Silymarin
More general drug interventions related to this trial
Antioxidants
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Sponsors listed in this trial
National Center for Complementary and Alternative Medicine (NCCAM)
Office of Dietary Supplements (ODS)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services